Profil
Paul A. Barsanti is Chief Technology Officer at IDEAYA Biosciences, Inc. since 2023.
Formerly, Dr. Barsanti was Head-Chemistry at Nurix Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree conferred in 1993 and a doctorate conferred in 1996, both from the University of Bath.
Aktiva positioner av Paul A. Barsanti
| Företag | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-03-01 |
Tidigare kända positioner av Paul A. Barsanti
| Företag | Position | Slut |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Företagsledare/Principal | 2018-06-01 |
Paul A. Barsantis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
















